TATAELXSI Q1 FY27 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹921.1 Cr
verification pending
Revenue YoY
6.5%
reported change
EBITDA
₹216 Cr
latest reported figure
Source
manual review required
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Tata Elxsi crossed the INR 1,000 crore quarterly revenue milestone in Q1 FY27, delivering INR 921.1 crore with 6.5% YoY CC growth. EBITDA came in at INR 216 crore (21.2% margin), expanding 80bps YoY but contracting 330bps sequentially due to 150bps one-time costs (customer transition, retention, provisions for a Chapter 11 customer) and 220bps investments in on-site delivery ramp-ups and subcontractors for large US deals. Transportation (55%+ of SD&A) grew 6.7% YoY CC with 78% OEM revenue mix, while Media & Communications delivered robust 11.5% YoY CC growth on deal ramp-ups. Healthcare remained flat. Management maintained high single-digit growth aspiration but flagged margin pressure from wage hikes in Q2 offsetting one-time cost normalization, with sequential margin improvement expected through Q4. Key risks include healthcare deal delays, European OEM softness, and AI spending redirecting R&D budgets.
Colored figures show movement against the previous available record.
Guidance to track
- Management maintained guidance for high single-digit revenue growth in FY27, contingent on healthcare segment firing up alongside continued strength in Transportation and Media & Communications verticals.
- Q2 margins will reflect wage hike costs offset by ~150bps of one-time costs going away, with sequential improvement expected through Q3-Q4 as revenue scales and ramp-up costs normalize.
- Neuron platform enabled Sky UK to achieve 30-70% efficiencies in network operations with enhanced cybersecurity; AIEL's Vital platform signed strategic deal with global medtech company.
- On-site subcontractor costs (90bps shift in offshore ratio) incurred due to visa delays and deal transition timelines will be replaced by own employees or moved offshore, normalizing within 2-3 quarters.
Risks flagged
- Healthcare posted near-flat QoQ performance (-0.3% CC) due to delayed deal awards from key customers despite strong AI/GenAI platform investments. This was raised by analysts and represents management's unmet expectation for Q1 growth recovery in the vertical.
- EBITDA margin declined 330bps QoQ to 21.2%, with 150bps one-time costs and 220bps strategic investments. While management expects recovery, wage hikes in Q2 partially offset one-time cost removal, creating uncertainty on margin trajectory.
- Germany and Continental Europe remain under pressure with slower ramp-ups of already-closed deals. Management flagged 'wait and watch' stance on new deal pace in Europe, representing 40%+ of automotive revenues.
- Nathan Pai noted that AI investments are 'curtailing R&D spend' as customers prioritize AI transformation over traditional R&D, potentially impacting volume growth and T&M project pipelines in the medium term.
Key quotes
- We have not been affected you know as much... there is some slowdown in the new deals but having said that I think for us the US market we were able to really significantly grow not just the automotive revenues but also the adjacency revenues including off-road and farm and equipment as well as the aerospace and defense segment.
- These investments definitely are around building specialized talent pool... we talked about the AI infrastructure that is needed that we're building so and also all the tools and the cloud investments that are needed to deliver value to our customers... and of course in some of the large deals that we have taken there is also the transition cost.
- When you're working with B2B customers in the chosen industries that we operate in which is healthcare, media, telecom as well as automotive and transportation... the industries that we operate in inverted it's quality time and then cost comes last. So to that extent I think the proposition stays strong which is Elxsi leading edge technology capabilities deep domain expertise now backed by AI.
Research modules